Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024GlobeNewsWire • 09/09/24
Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024GlobeNewsWire • 09/03/24
Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024GlobeNewsWire • 07/02/24
Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024GlobeNewsWire • 07/01/24
Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability PerformanceGlobeNewsWire • 05/23/24
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Avid Bioservices, Inc. - CDMOPRNewsWire • 05/17/24
Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024GlobeNewsWire • 04/24/24
Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-QGlobeNewsWire • 03/20/24
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of InvestorsBusiness Wire • 03/14/24
Avid Bioservices, Inc. (CDMO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged WrongdoingsBusiness Wire • 03/14/24
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of InvestorsBusiness Wire • 03/14/24
The Law Offices of Frank R. Cruz Announces Investigation of Avid Bioservices, Inc. (CDMO) on Behalf of InvestorsBusiness Wire • 03/13/24
CDMO LOSS ALERT: ROSEN, A LEADING LAW FIRM, Encourages Avid Bioservices, Inc. Investors to Inquire About Securities Class Action Investigation – CDMOBusiness Wire • 03/07/24
Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024GlobeNewsWire • 03/06/24